Effect of angiotensin II type 1 receptor blockade on kidney ischemia/reperfusion; a gender-related difference

Fatemeh Moslemi ¹, Pegah Taheri ¹, Mahdis Azimipoor ¹, Sina Ramtin ¹, Mostafa Hashemianfar ¹, Ali Momeni- Ashjerdi ¹, Fatemeh Eshraghi-Jazi ¹, Ardeshir Talebi ¹, Hamid Nasri ¹, Mehdi Nematbakhsh ^1,2,3 *

Cited by CrossRef: 7

1- Sharma N, Anders H, Gaikwad A. Fiend and friend in the renin angiotensin system: An insight on acute kidney injury. Biomedicine & Pharmacotherapy. 2019;110:764 [Crossref]

2- Hayes M. Bioactive Peptides in Preventative Healthcare: An Overview of Bioactivities and Suggested Methods to Assess Potential Applications. CPD. 2021;27(11):1332 [Crossref]

3- Talebi A, Emami F, Biranvand R, Moosavi Z, Ramtin K, Sadeghi S, Baghaei K, Lak Z, Nematbakhsh M. Protective Role of Angiotensin II Type 1 Receptor Blocker on Short Time Effect of Oleic Acid Induced Lung and Kidney Injury. Int J Prev Med. 2021;12(1):4 [Crossref]

4- Zhang Z, Qian L, Wang R. Molecular Mechanisms Underlying Renin-Angiotensin-Aldosterone System Mediated Regulation of BK Channels. Front Physiol. 2017;8 [Crossref]

5- Uduagbamen P, Sanusi M, Udom O. Original Research Gender Differences in Recovering from Cardiac and Vascular Surgery Associated Acute Kidney Injury. 2023;22(2):160 [Crossref]

6- Koc K, Geyikoglu F, Cakmak O, Koca A, Kutlu Z, Aysin F, Yilmaz A, Aşkın H. The targets of β-sitosterol as a novel therapeutic against cardio-renal complications in acute renal ischemia/reperfusion damage. Naunyn-Schmiedeberg's Arch Pharmacol. 2021;394(3):469 [Crossref]

7- Lima-Posada I, Portas-Cortés C, Pérez-Villalva R, Fontana F, Rodríguez-Romo R, Prieto R, Sánchez-Navarro A, Rodríguez-González G, Gamba G, Zambrano E, Bobadilla N. Gender Differences in the Acute Kidney Injury to Chronic Kidney Disease Transition. Sci Rep. 2017;7(1) [Crossref]